Here, decreased expression of PTX3 post rBmK AGAP treatment correlated with decreased IKKα, p65/NF-κB, TNF-α, and NF-κB DNA binding and transcription activity inhibiting breast cancer cell stemness and epithelial-mesenchymal transition. The gene discussed is PTX3; the disease is breast carcinoma.